Q9UKK9 (NUDT5_HUMAN) Homo sapiens (Human)
ADP-sugar pyrophosphatase UniProtKBInterProSTRINGInteractive Modelling
219 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
64 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal structure of human ADP-ribose pyrophosphatase NUDT5 | homo-2-mer | |||||
Assess | ||||||
Crystal Structure of Human ADP-ribose Pyrophosphatase NUDT5 In complex with magnesium and AMPcpr | homo-2-mer | 6×MG; 2×ADV; | ||||
Assess | ||||||
Crystal structure of human NUDT5 complexed with 8-oxo-dADP and manganese | homo-2-mer | 5×MN; 2×8DD; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 2×K31; 3×EDO; 1×CL; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×K0J; 3×EDO; 1×CL; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K34; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 1×EDO; 2×K1P; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×K3M; 3×EDO; 1×CL; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K2V; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-3764 | homo-2-mer | 4×MG; 3×EDO; 2×PWP; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K1S; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 1×K3Y; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 2×K3V; 2×EDO; 1×CL; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 2×JMM; 3×EDO; 1×CL; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K2M; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K0V; 3×EDO; | ||||
Assess | ||||||
Ground-state model of NUDT5 and corresponding apo datasets for PanDDA analysis | homo-2-mer | 4×MG; 1×CL; 1×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 1×K1Y; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 1×K2J; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 1×K0M; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×K24; 3×EDO; 1×CL; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 2×K1V; 3×EDO; 1×CL; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 2×K3D; 2×EDO; 1×CL; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K3J; 3×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×EDO; 1×K0S; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K0A; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K1D; 3×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 2×EDO; 1×CL; 1×JH4; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 3×EDO; 1×GQJ; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×EDO; 2×K3P; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K07; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 4×EDO; 2×JJM; | ||||
Assess | ||||||
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with 1R-0641 | homo-2-mer | 4×MG; 1×CL; 2×PWG; 3×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×EDO; 1×K1A; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×K3A; 2×EDO; 1×CL; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 3×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 1×K3S; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with Z44592329 | homo-2-mer | 4×MG; 1×CL; 2×K0G; 1×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with AE-0227 | homo-2-mer | 4×MG; 2×PWJ; 4×EDO; 1×CL; | ||||
Assess | ||||||
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with GB-0804 | homo-2-mer | 4×MG; 1×CL; 3×EDO; 2×PW7; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×EDO; 1×K2P; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 2×K1G; 1×CL; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 3×EDO; 1×K0P; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 1×EDO; 1×ELQ; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K1J; 4×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K2S; 3×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K2G; 3×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-2639 | homo-2-mer | 4×MG; 1×CL; 2×PWA; 3×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-1169 | homo-2-mer | 4×MG; 2×PWM; 3×EDO; 1×CL; | ||||
Assess | ||||||
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with SS-4432 | homo-2-mer | 4×MG; 1×CL; 2×PWD; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K0D; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with 8J-537S | homo-2-mer | 4×MG; 1×CL; 2×PWS; 5×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 2×K04; 2×EDO; 1×CL; | ||||
Assess | ||||||
Crystal structure of human NUDT5 | homo-2-mer | 4×MG; 1×CL; 1×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 2×K41; 2×EDO; | ||||
Assess | ||||||
Crystal structure of human ADP-ribose pyrophosphatase NUDT5 in complex with magnesium and ADP-ribose | homo-2-mer | 2×MG; 2×APR; | ||||
Assess | ||||||
Crystal Structure of Human ADP-ribose Pyrophosphatase NUDT5 In complex with Ibrutinib | homo-2-mer | 4×MG; 2×A1H14; 2×EDO; | ||||
Assess | ||||||
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | homo-2-mer | 4×MG; 1×CL; 1×K0Y; 2×EDO; | ||||
Assess | ||||||
Crystal structure of human NUDT5 complexed with 8-oxo-dGDP and manganese | homo-2-mer | 2×8GD; 2×MN; | ||||
Assess | ||||||
Potent inhibitors of NUDT5 silence hormone signaling in breast cancer | homo-2-mer | 3×958; | ||||
Assess | ||||||
Human NUDT5 with ibrutinib derivative | homo-2-mer | 2×W0O; | ||||
Assess | ||||||
Crystal structure of human NUDT5 complexed with 8-oxo-dGMP | homo-2-mer | 2×8OG; | ||||
Assess | ||||||
Crystal structure of human ADP-ribose pyrophosphatase NUDT5 in complex with magnesium and AMP | homo-2-mer | 6×MG; 2×AMP; | ||||
Assess | ||||||
Potent inhibitors of NUDT5 silence hormone signaling in breast cancer | homo-2-mer | 2×9CH; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
2dsb.1.A | homo-2-mer | 0.86 | 100.00 | |||
Assess |